Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

Recruiting Observational Study
Atrial Fibrillation
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
825 (estimated)
Sponsor
Saint Antoine University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of the present prospective study is to further develop and validate a composite risk score predicting both ischemic and bleeding risk, based on epidemiologic, clinical, biological, and/or morphologic complementary data. First, the investigators will assess the predictive performance of current clinical risk scores. Second, the investigators will assess the potential predictive value of add…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults above 18 years of age * Presenting a NVAF which is paroxysmal, persistent or permanent and documented by an electrocardiogram (ECG) * Willing and able to give written informed consent Exclusion Criteria: * Patients presenting a clinically and echocardiographically sig…
Contacts

Ariel Cohen, MD, PhD

+33149282886

ariel.cohen@aphp.fr

CONTACT

Sylvie Lang, PhD

+33689742859

sylvie.lang@aphp.fr

CONTACT